Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Jojoba Oil for far more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
11
uses studied
17
papers cited
0
hidden from you
What the published studies found
Early evidence · 2 studies
Acne
The only human evidence is a single open-label, uncontrolled pilot study (n=194) in which a clay–jojoba oil facial mask produced a ~54% mean reduction in acne lesion counts over 6 weeks; because it had no control group and used a clay+jojoba combination, the effect cannot be attributed to jojoba alone. Supporting ex-vivo research shows jojoba wax reduces pro-inflammatory cytokines (IL-6, IL-8, TNFα ~30%) in human skin organ culture, providing mechanistic plausibility but no clinical confirmation.
The retrieved evidence for jojoba oil on skin aging/wrinkles consists of a narrative review (PMID 29280987) describing jojoba among ~19 plant oils with anti-inflammatory, antioxidant, and skin barrier–repair properties that could plausibly benefit aging skin, but no clinical trials specifically testing jojoba for wrinkle reduction were found; a second retrieved study (PMID 19427472) concerns oxidative aging/stability of the oil itself, not human skin. There are no RCTs or systematic reviews demonstrating anti-wrinkle efficacy of jojoba oil.
Evidence for jojoba oil in wound healing is limited to preclinical work: an in vitro study using reconstructed human epidermis found jojoba oil (particularly unrefined 'golden') upregulated wound-healing genes (ANGPTL4, MMP9) without irritation markers, and a rat study showed a tea tree + jojoba nano-emulgel enhanced wound closure, reduced inflammatory markers (TNF-α, IL-1β), and improved collagen deposition versus controls. No human clinical trials were identified among the visible results.
Evidence for jojoba oil and dry skin is limited to mechanistic and formulation research: a small in vivo comparative study (n=16, adults and infants) showed jojoba oil penetrates the upper stratum corneum and provides modest occlusion (10-20% SC swelling vs 40-60% for petrolatum), supporting a plausible moisturizing mechanism, while a separate study characterized a jojoba oil-based oleogel proposed for very dry skin care. No clinical trials have directly tested jojoba oil as a treatment for dry skin conditions.
Only two studies mention jojoba in the context of joint disease, and in both it served only as a minor carrier oil (10% of an aromatherapy massage base) or as a formulation excipient in a curcumin–arnica transdermal patch. No study evaluated jojoba oil itself as an anti-inflammatory or anti-arthritic agent, so any observed benefits cannot be attributed to jojoba.
No human clinical trials were found testing jojoba oil for muscle pain. The only supporting evidence is a narrative review (PMID 34073772) that lists 'analgesic' among jojoba oil's reported preclinical pharmacological activities, and an animal study (PMID 30767746) of a curcumin/arnica transdermal patch in which jojoba oil was merely a formulation excipient affecting drug release and patch flexibility, not the active analgesic agent.
The only retrieved study (PMID 24772476) is a cosmetic formulation study of nanostructured lipid carrier gels containing jojoba oil (or argan oil) that showed improved skin hydration and reduced transepidermal water loss in healthy volunteers. Eczema was mentioned only as background context; no eczema patients were enrolled and jojoba's individual contribution cannot be isolated from the multi-ingredient formulation.
The only fully visible relevant result is a 2021 comprehensive narrative review of jojoba oil (PMID 34073772) that lists antifungal activity among its pharmacological properties, based on preclinical/in-vitro findings. No human clinical trials, RCTs, or systematic reviews evaluating jojoba oil for treating fungal infections were identified in the visible results.
The only study found is an in vitro pilot study (Skin-PAMPA artificial membrane assay) showing that 10% jojoba oil enhanced retinol membrane permeation ~40-fold; hyperpigmentation is mentioned only as a known benefit of retinol in the introduction, not as an outcome measured. No clinical, animal, or cell-based studies directly testing jojoba oil for hyperpigmentation were identified.
The only directly relevant retrievable study (PMID 38344180) is an ex-vivo human skin organ culture study showing topical jojoba wax reduced LPS-induced pro-inflammatory cytokines (IL-6, IL-8, TNFα) by ~30% and boosted pro-collagen III and hyaluronic acid synthesis; its psoriasis relevance is indirect, citing prior reports that jojoba 'ameliorates psoriasis manifestations' rather than testing psoriasis itself. No RCTs, controlled clinical trials, or systematic reviews of jojoba for psoriasis appear in these results.
The retrieved literature does not contain studies evaluating jojoba oil as a treatment for rash or contact dermatitis. The one verifiable result (PMID 20195063) is a mouse study of German chamomile oil for atopic dermatitis in which jojoba oil served only as an inactive control vehicle—and the chamomile group outperformed the jojoba control group. Jojoba's skin use rests on traditional/cosmetic emollient application, not clinical evidence for treating dermatitis.
